tetano
Editor, Senior Moderator
Eur J Public Health
. 2021 Sep 17;ckab143.
doi: 10.1093/eurpub/ckab143. Online ahead of print.
Trend of antibiotic consumption and its association with influenza-like illnesses in France between 2004 and 2018
Sally Yaacoub[SUP] 1 [/SUP], Emilie Lanoy[SUP] 2 3 [/SUP], Karima Hider-Mlynarz[SUP] 4 [/SUP], Nadine Saleh[SUP] 5 6 7 [/SUP], Patrick Maison[SUP] 1 4 8 [/SUP]
Affiliations
Abstract
Background: Antibiotic consumption has been reported to be driven by the treatment of respiratory tract infections. Our objectives were to describe the trend of antibiotic consumption in France compared with that of other European countries; to describe the evolution of each antibiotic class in France; and to explore the relationship between antibiotic consumption and incidence of influenza-like illnesses.
Methods: In this observational study, antibiotic consumption was reported as defined daily doses per 1000 inhabitants per day in the community and hospital sectors in descriptive and graphical formats, using data from the European Surveillance of Antimicrobial Consumption Network database. The total consumption and the consumption of different classes of antibiotics in France according to time and influenza-like illnesses were studied using multiple linear regression models.
Results: The total consumption of antibiotics in France was constant over the 15 years. It was driven by the community sector (92.8%) and was higher than the consumption of other European Union countries (P-value < 0.001). The beta-lactam penicillins were the most consumed antibiotic class and the only class that increased with time. The multiple linear regression models showed a positive correlation between antibiotic consumption in the community sector and incidence of influenza-like illnesses [B = 0.170, 95% CI (0.088-0.252)]. Similar significant results were shown between other antibiotic classes used in the management of influenza-like illnesses (other beta-lactams, and macrolides, lincosamides and streptogramins) and influenza-like illnesses.
Conclusion: Our results suggest that antibiotics used in the management of respiratory tract infections might be involved in the irrational use of antibiotics.
. 2021 Sep 17;ckab143.
doi: 10.1093/eurpub/ckab143. Online ahead of print.
Trend of antibiotic consumption and its association with influenza-like illnesses in France between 2004 and 2018
Sally Yaacoub[SUP] 1 [/SUP], Emilie Lanoy[SUP] 2 3 [/SUP], Karima Hider-Mlynarz[SUP] 4 [/SUP], Nadine Saleh[SUP] 5 6 7 [/SUP], Patrick Maison[SUP] 1 4 8 [/SUP]
Affiliations
- PMID: 34534281
- DOI: 10.1093/eurpub/ckab143
Abstract
Background: Antibiotic consumption has been reported to be driven by the treatment of respiratory tract infections. Our objectives were to describe the trend of antibiotic consumption in France compared with that of other European countries; to describe the evolution of each antibiotic class in France; and to explore the relationship between antibiotic consumption and incidence of influenza-like illnesses.
Methods: In this observational study, antibiotic consumption was reported as defined daily doses per 1000 inhabitants per day in the community and hospital sectors in descriptive and graphical formats, using data from the European Surveillance of Antimicrobial Consumption Network database. The total consumption and the consumption of different classes of antibiotics in France according to time and influenza-like illnesses were studied using multiple linear regression models.
Results: The total consumption of antibiotics in France was constant over the 15 years. It was driven by the community sector (92.8%) and was higher than the consumption of other European Union countries (P-value < 0.001). The beta-lactam penicillins were the most consumed antibiotic class and the only class that increased with time. The multiple linear regression models showed a positive correlation between antibiotic consumption in the community sector and incidence of influenza-like illnesses [B = 0.170, 95% CI (0.088-0.252)]. Similar significant results were shown between other antibiotic classes used in the management of influenza-like illnesses (other beta-lactams, and macrolides, lincosamides and streptogramins) and influenza-like illnesses.
Conclusion: Our results suggest that antibiotics used in the management of respiratory tract infections might be involved in the irrational use of antibiotics.